Filing Details
- Accession Number:
- 0001562180-21-005940
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-14 16:05:29
- Reporting Period:
- 2021-09-10
- Accepted Time:
- 2021-09-14 16:05:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1770121 | Sana Biotechnology Inc. | SANA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1830070 | Christian Hordo | C/O Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 Seattle WA 98102 | Evp, Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-09-10 | 1,477 | $25.00 | 942,455 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.